Terms: = Kidney tumors AND DAXX, BING2, 1616, ENSG00000206206, MGC126246, Q9UER7, MGC126245, DAQB-126H3_2, DAP6
34677 results:
1. Risk Factors for Teicoplanin-Associated Acute kidney Injury in Patients with Hematological Malignancies: Focusing on Concomitant Use of Tazobactam/Piperacillin.
Morinaga Y; Tanaka R; Tatsuta R; Takano K; Hashimoto T; Ogata M; Hiramatsu K; Itoh H
Biol Pharm Bull; 2024; 47(5):988-996. PubMed ID: 38763761
[TBL] [Abstract] [Full Text] [Related]
2. Tumor infiltrating B lymphocytes (TIBs) associate with poor clinical outcomes, unfavorable therapeutic benefit and immunosuppressive context in metastatic clear cell renal cell carcinoma (mccRCC) patients treated with anti-PD-1 antibody plus Axitinib.
Lin Z; Xiao S; Qi Y; Guo J; Lu L
J Cancer Res Clin Oncol; 2024 May; 150(5):262. PubMed ID: 38762825
[TBL] [Abstract] [Full Text] [Related]
3. Potential drug targets for tumors identified through Mendelian randomization analysis.
Song N; Shi P; Cui K; Zeng L; Wang Z; Di W; Li J; Fan Y; Li Z; Zhang J; Su W; Wang H
Sci Rep; 2024 May; 14(1):11370. PubMed ID: 38762700
[TBL] [Abstract] [Full Text] [Related]
4. Contrast-enhanced ultrasound for differentiating benign from malignant focal solid renal lesions in pediatric patients.
Fu Y; Zhong J; Tan Y; Zheng T; Liu M; Wang G
Sci Rep; 2024 May; 14(1):11409. PubMed ID: 38762673
[TBL] [Abstract] [Full Text] [Related]
5. Association between metabolic syndrome and kidney cancer risk: a prospective cohort study.
Wang L; Du H; Sheng C; Dai H; Chen K
Lipids Health Dis; 2024 May; 23(1):142. PubMed ID: 38760801
[TBL] [Abstract] [Full Text] [Related]
6. A population-based study on incidence trends of kidney and renal pelvis cancers in the United States over 2000-2020.
Mousavi SE; Najafi M; Aslani A; Fazlollahi A; Yekta Z; Sadri M; Nejadghaderi SA
Sci Rep; 2024 May; 14(1):11294. PubMed ID: 38760399
[TBL] [Abstract] [Full Text] [Related]
7. Evaluating the effects of various ethanolic medicinal plant extracts on metastatic breast cancer proliferation, invasion, and expression of a novel potential drug target; CD82 metastatic suppressor protein, and on in vivo angiogenesis using the ex ovo yolk sac membrane (YSM) assay.
Loggenberg S; Twilley D; Lall N
J Cancer Res Clin Oncol; 2024 May; 150(5):257. PubMed ID: 38753184
[TBL] [Abstract] [Full Text] [Related]
8. End-stage renal disease after renal cancer surgery: risk factors and overall survival.
Åkerlund J; Ljungberg B; Lundstam S; Peeker R; Holmberg E; Månsson M; Grenabo Bergdahl A
Scand J Urol; 2024 May; 59():109-116. PubMed ID: 38747153
[TBL] [Abstract] [Full Text] [Related]
9. Endoscopic intervention versus radical nephroureterectomy for the management of localized upper urinary tract urothelial carcinoma: a systematic review and meta-analysis of comparative studies.
Giulioni C; Brocca C; Tramanzoli P; Stramucci S; Mantovan M; Perpepaj L; Cicconofri A; Gauhar V; Merseburger AS; Galosi AB; Castellani D
World J Urol; 2024 May; 42(1):318. PubMed ID: 38743260
[TBL] [Abstract] [Full Text] [Related]
10. Deep Learning Assessment of Small Renal Masses at Contrast-enhanced Multiphase CT.
Dai C; Xiong Y; Zhu P; Yao L; Lin J; Yao J; Zhang X; Huang R; Wang R; Hou J; Wang K; Shi Z; Chen F; Guo J; Zeng M; Zhou J; Wang S
Radiology; 2024 May; 311(2):e232178. PubMed ID: 38742970
[TBL] [Abstract] [Full Text] [Related]
11. Minimally invasive transperitoneal partial versus radical nephrectomy in obese patients: perioperative and long-term functional outcomes from a large perspective contemporary series (RECORd2 project).
Lambertini L; Mari A; Sandulli A; Amparore D; Antonelli A; Barale M; Bove P; Brunocilla E; Capitanio U; DA Pozzo LF; DI Maida F; Grosso AA; Fiori C; Gontero P; Li Marzi V; Campi R; Longo N; Marchioni M; Montanari E; Montorsi F; Porpiglia F; Porreca A; Schiavina R; Simeone C; Siracusano S; Terrone C; Ficarra V; Minervini A
Minerva Urol Nephrol; 2024 Apr; 76(2):185-194. PubMed ID: 38742553
[TBL] [Abstract] [Full Text] [Related]
12. Single-layer versus double-layer renorrhaphy technique during robot-assisted partial nephrectomy: impact on perioperative outcomes, complications, and functional outcomes.
Bertolo R; Ditonno F; Veccia A; DE Marco V; Migliorini F; Porcaro AB; Rizzetto R; Cerruto MA; Autorino R; Antonelli A
Minerva Urol Nephrol; 2024 Apr; 76(2):176-184. PubMed ID: 38742552
[TBL] [Abstract] [Full Text] [Related]
13. An epidemiological and clinicopathological study of type 1 vs. type 2 morphological subtypes of papillary renal cell carcinoma- results from a nation-wide study covering 50 years in Iceland.
Runarsson TG; Bergmann A; Erlingsdottir G; Petursdottir V; Heitmann LA; Johannesson A; Asbjornsson V; Axelsson T; Hilmarsson R; Gudbjartsson T
BMC Urol; 2024 May; 24(1):105. PubMed ID: 38741053
[TBL] [Abstract] [Full Text] [Related]
14. Projected estimates of cancer in Canada in 2024.
Brenner DR; Gillis J; Demers AA; Ellison LF; Billette JM; Zhang SX; Liu JL; Woods RR; Finley C; Fitzgerald N; Saint-Jacques N; Shack L; Turner D;
CMAJ; 2024 May; 196(18):E615-E623. PubMed ID: 38740416
[TBL] [Abstract] [Full Text] [Related]
15. Seven oral traditional Chinese medicine combined with chemotherapy for the treatment of non-small cell lung cancer: a network meta-analysis.
Liu K; Li Q; Lu X; Fan X; Yang Y; Xie W; Kang J; Sun S; Zhao J
Pharm Biol; 2024 Dec; 62(1):404-422. PubMed ID: 38739082
[TBL] [Abstract] [Full Text] [Related]
16. SPP1 expression indicates outcome of immunotherapy plus tyrosine kinase inhibition in advanced renal cell carcinoma.
Xu X; Lin J; Wang J; Wang Y; Zhu Y; Wang J; Guo J
Hum Vaccin Immunother; 2024 Dec; 20(1):2350101. PubMed ID: 38738709
[TBL] [Abstract] [Full Text] [Related]
17. Utility of Chemical Shift Imaging and Diffusion-weighted Images/Apparent Diffusion Coefficient Maps as a Tool for Evaluation of Solid Renal tumors.
Sharma S; Gupta R; Bhalla V; Aggarwal P; Gulati M
J Assoc Physicians India; 2024 Mar; 72(3):18-23. PubMed ID: 38736111
[TBL] [Abstract] [Full Text] [Related]
18. Acetylation- and ubiquitination-regulated SFMBT2 acts as a tumor suppressor in clear cell renal cell carcinoma.
Xie Q; Hu B; Li H
Biol Direct; 2024 May; 19(1):37. PubMed ID: 38734627
[TBL] [Abstract] [Full Text] [Related]
19. Comparison of Perioperative, Functional, and Oncologic Outcomes of Open vs. Robot-Assisted Off-Clamp Partial Nephrectomy: A Propensity Scored Match Analysis.
Mastroianni R; Chiacchio G; Perpepaj L; Tuderti G; Brassetti A; Anceschi U; Ferriero M; Misuraca L; D'Annunzio S; Bove AM; Guaglianone S; Flammia RS; Proietti F; Pula M; Milanese G; Leonardo C; Galosi AB; Simone G
Sensors (Basel); 2024 Apr; 24(9):. PubMed ID: 38732928
[TBL] [Abstract] [Full Text] [Related]
20. Effects of a Personalized Diet on Nutritional Status and Renal Function Outcome in Nephrectomized Patients with Renal Cancer.
Trevisani F; Laurenti F; Fiorio F; Paccagnella M; Floris M; Capitanio U; Ghidini M; Garrone O; Abbona A; Salonia A; Montorsi F; Bettiga A
Nutrients; 2024 May; 16(9):. PubMed ID: 38732632
[TBL] [Abstract] [Full Text] [Related]
[Next]
